187 related articles for article (PubMed ID: 31869496)
1. Annexin A6 improves anti-migratory and anti-invasive properties of tyrosine kinase inhibitors in EGFR overexpressing human squamous epithelial cells.
Hoque M; Elmaghrabi YA; Köse M; Beevi SS; Jose J; Meneses-Salas E; Blanco-Muñoz P; Conway JRW; Swarbrick A; Timpson P; Tebar F; Enrich C; Rentero C; Grewal T
FEBS J; 2020 Jul; 287(14):2961-2978. PubMed ID: 31869496
[TBL] [Abstract][Full Text] [Related]
2. Annexin A6 is a scaffold for PKCα to promote EGFR inactivation.
Koese M; Rentero C; Kota BP; Hoque M; Cairns R; Wood P; Vilà de Muga S; Reverter M; Alvarez-Guaita A; Monastyrskaya K; Hughes WE; Swarbrick A; Tebar F; Daly RJ; Enrich C; Grewal T
Oncogene; 2013 Jun; 32(23):2858-72. PubMed ID: 22797061
[TBL] [Abstract][Full Text] [Related]
3. SUMOylation of AnxA6 facilitates EGFR-PKCα complex formation to suppress epithelial cancer growth.
Sheng Z; Cao X; Deng YN; Zhao X; Liang S
Cell Commun Signal; 2023 Aug; 21(1):189. PubMed ID: 37528485
[TBL] [Abstract][Full Text] [Related]
4. Reduced annexin A6 expression promotes the degradation of activated epidermal growth factor receptor and sensitizes invasive breast cancer cells to EGFR-targeted tyrosine kinase inhibitors.
Koumangoye RB; Nangami GN; Thompson PD; Agboto VK; Ochieng J; Sakwe AM
Mol Cancer; 2013 Dec; 12(1):167. PubMed ID: 24354805
[TBL] [Abstract][Full Text] [Related]
5. Annexin A6 inhibits Ras signalling in breast cancer cells.
Vilá de Muga S; Timpson P; Cubells L; Evans R; Hayes TE; Rentero C; Hegemann A; Reverter M; Leschner J; Pol A; Tebar F; Daly RJ; Enrich C; Grewal T
Oncogene; 2009 Jan; 28(3):363-77. PubMed ID: 18850003
[TBL] [Abstract][Full Text] [Related]
6. Lapatinib-induced annexin A6 upregulation as an adaptive response of triple-negative breast cancer cells to EGFR tyrosine kinase inhibitors.
Widatalla SE; Korolkova OY; Whalen DS; Goodwin JS; Williams KP; Ochieng J; Sakwe AM
Carcinogenesis; 2019 Aug; 40(8):998-1009. PubMed ID: 30590459
[TBL] [Abstract][Full Text] [Related]
7. Annexin A6-A multifunctional scaffold in cell motility.
Grewal T; Hoque M; Conway JRW; Reverter M; Wahba M; Beevi SS; Timpson P; Enrich C; Rentero C
Cell Adh Migr; 2017 May; 11(3):288-304. PubMed ID: 28060548
[TBL] [Abstract][Full Text] [Related]
8. Intracellular modulation of signaling pathways by annexin A6 regulates terminal differentiation of chondrocytes.
Minashima T; Small W; Moss SE; Kirsch T
J Biol Chem; 2012 Apr; 287(18):14803-15. PubMed ID: 22399299
[TBL] [Abstract][Full Text] [Related]
9. FGFR Inhibition Overcomes Resistance to EGFR-targeted Therapy in Epithelial-like Cutaneous Carcinoma.
Bernat-Peguera A; Navarro-Ventura J; Lorenzo-Sanz L; da Silva-Diz V; Bosio M; Palomero L; Penin RM; Pérez Sidelnikova D; Bermejo JO; Taberna M; Vilariño N; Piulats JM; Mesia R; Viñals JM; González-Suárez E; Capella-Gutierrez S; Villanueva A; Viñals F; Muñoz P
Clin Cancer Res; 2021 Mar; 27(5):1491-1504. PubMed ID: 33262138
[TBL] [Abstract][Full Text] [Related]
10. Elevated RET expression enhances EGFR activation and mediates EGFR inhibitor resistance in head and neck squamous cell carcinoma.
Lin C; Lu W; Ren Z; Tang Y; Zhang C; Yang R; Chen Y; Cao W; Wang L; Wang X; Ji T
Cancer Lett; 2016 Jul; 377(1):1-10. PubMed ID: 27090738
[TBL] [Abstract][Full Text] [Related]
11. Acquired resistance to EGFR tyrosine kinase inhibitors in cancer cells is mediated by loss of IGF-binding proteins.
Guix M; Faber AC; Wang SE; Olivares MG; Song Y; Qu S; Rinehart C; Seidel B; Yee D; Arteaga CL; Engelman JA
J Clin Invest; 2008 Jul; 118(7):2609-19. PubMed ID: 18568074
[TBL] [Abstract][Full Text] [Related]
12. Annexin A6 stimulates the membrane recruitment of p120GAP to modulate Ras and Raf-1 activity.
Grewal T; Evans R; Rentero C; Tebar F; Cubells L; de Diego I; Kirchhoff MF; Hughes WE; Heeren J; Rye KA; Rinninger F; Daly RJ; Pol A; Enrich C
Oncogene; 2005 Sep; 24(38):5809-20. PubMed ID: 15940262
[TBL] [Abstract][Full Text] [Related]
13. Annexin A6 and Late Endosomal Cholesterol Modulate Integrin Recycling and Cell Migration.
García-Melero A; Reverter M; Hoque M; Meneses-Salas E; Koese M; Conway JR; Johnsen CH; Alvarez-Guaita A; Morales-Paytuvi F; Elmaghrabi YA; Pol A; Tebar F; Murray RZ; Timpson P; Enrich C; Grewal T; Rentero C
J Biol Chem; 2016 Jan; 291(3):1320-35. PubMed ID: 26578516
[TBL] [Abstract][Full Text] [Related]
14. Exosomal annexin A6 induces gemcitabine resistance by inhibiting ubiquitination and degradation of EGFR in triple-negative breast cancer.
Li T; Tao Z; Zhu Y; Liu X; Wang L; Du Y; Cao J; Wang B; Zhang J; Hu X
Cell Death Dis; 2021 Jul; 12(7):684. PubMed ID: 34238922
[TBL] [Abstract][Full Text] [Related]
15. Annexin A6 and NPC1 regulate LDL-inducible cell migration and distribution of focal adhesions.
Jose J; Hoque M; Engel J; Beevi SS; Wahba M; Georgieva MI; Murphy KJ; Hughes WE; Cochran BJ; Lu A; Tebar F; Hoy AJ; Timpson P; Rye KA; Enrich C; Rentero C; Grewal T
Sci Rep; 2022 Jan; 12(1):596. PubMed ID: 35022465
[TBL] [Abstract][Full Text] [Related]
16. Molecular imaging of gefitinib activity in an epidermal growth factor receptor (EGFR)-bearing xenograft model.
Gong J; Yang DJ; Kohanim S; Angelo LS; Kurzrock R
Cancer Biol Ther; 2009 Dec; 8(23):2239-47. PubMed ID: 19823028
[TBL] [Abstract][Full Text] [Related]
17. Amlodipine, a Ca2+ channel blocker, suppresses phosphorylation of epidermal growth factor receptor in human epidermoid carcinoma A431 cells.
Yoshida J; Ishibashi T; Yang M; Nishio M
Life Sci; 2010 Jan; 86(3-4):124-32. PubMed ID: 19951711
[TBL] [Abstract][Full Text] [Related]
18. Annexin A6 contributes to the invasiveness of breast carcinoma cells by influencing the organization and localization of functional focal adhesions.
Sakwe AM; Koumangoye R; Guillory B; Ochieng J
Exp Cell Res; 2011 Apr; 317(6):823-37. PubMed ID: 21185831
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia-Inducible Expression of Annexin A6 Enhances the Resistance of Triple-Negative Breast Cancer Cells to EGFR and AR Antagonists.
Williams SD; Smith TM; Stewart LV; Sakwe AM
Cells; 2022 Sep; 11(19):. PubMed ID: 36230969
[TBL] [Abstract][Full Text] [Related]
20. Oridonin inhibited the tyrosine kinase activity and induced apoptosis in human epidermoid carcinoma A431 cells.
Li D; Wu LJ; Tashiro S; Onodera S; Ikejima T
Biol Pharm Bull; 2007 Feb; 30(2):254-60. PubMed ID: 17268061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
